https://news.augustaheadlines.com/story/511442/delightful-new-childrens-book-where-is-wyatt-by-ashley-kidd-sparks-laughter-and-curiosity.html 2025-03-26T12:04:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/511440/her2positive-breast-cancer-pipeline-2025-therapies-moa-insights-and-key-clinical-trial-updates-by-delveinsight-roche-pharma-ag-dizal-pharma-greenwich-lifesciences-ambrx-alteogen.html 2025-03-26T10:52:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/511439/a-timeless-journey-through-faith-family-and-life-lessons-david-dollison-sr-releases-psalms-in-the-key-of-life-a-powerful-memoir-reflecting-on-the-values-of-a-bygone-era.html 2025-03-26T10:48:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/511438/new-contemplative-work-explores-the-intersection-of-faith-morality-and-the-american-experience-in-an-era-of-rapid-cultural-shifts-and-deep-societal-reflection-a-compelling-new-literary-work-emerges.html 2025-03-26T10:46:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/511437/yubo-a-revolutionary-logistics-and-transportation-solution.html 2025-03-26T10:30:07+00:00 daily 1.0 https://news.augustaheadlines.com/story/511436/hepatic-encephalopathy-market-to-show-remarkable-growth-trends-from-2024-to-2034-delveinsight-reports-salix-pharma-bausch-health-axcella-health-umecrine-cognition-vedanta-biosciences.html 2025-03-26T10:26:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/511435/myopia-pipeline-2025-fda-approvals-and-clinical-trials-landscape-with-moa-and-roa-highlights-by-delveinsight-ziemer-group-nidek-co-ltd-2eyesvision-carl-zeiss-ag-alcon-coopervision.html 2025-03-26T09:52:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/511434/dravet-syndrome-market-expected-to-experience-major-growth-by-2034-according-to-delveinsight-takeda-eisai-stoke-therapeutics-epygenix-therapeutic-marinus-pharma-stoke-therapeutics-jazz-pharma.html 2025-03-26T09:30:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/511433/nonsmall-cell-lung-cancer-market-set-to-grow-substantially-through-2034-delveinsight-projects-abbvie-xcovery-sanofi-neoimmune-tech-merck-kgaa-and-pfizer-mirati-therapeutics-astrazeneca.html 2025-03-26T08:52:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/511432/surgical-site-infections-market-poised-for-transformative-growth-by-2034-predicts-delveinsight.html 2025-03-26T07:58:02+00:00 daily 1.0